{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-329513","form_type":"8-K","ticker":"INDV","cik":"0001625297","company_name":"Indivior Pharmaceuticals, Inc.","filed_at":"2026-08-03T10:40:42+00:00","discovered_at":"2026-08-03T10:45:00.882109+00:00","generated_at":"2026-08-03T10:45:08.552150+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Indivior to merge with Supernus in stock-for-stock deal; Indivior stockholders to own 56.5% of combined company","bullets":["Exchange ratio: 1.5401 Indivior shares per Supernus share; Indivior stockholders own ~56.5%, Supernus ~43.5% on fully diluted basis.","Indivior to pay $1B special dividend pre-closing, funded in part by $650M senior secured term loan from Citibank.","Combined company renamed Supernus, Inc., trades on Nasdaq under 'SUPN'; Jack Khattar CEO, Timothy Dec CFO; board split 4-4.","Termination fees: Indivior pays $174M if it walks for superior proposal; Supernus pays $101M; closing subject to stockholder and regulatory approvals."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-329513","json":"https://secwatch.observer/filing/0001193125-26-329513.json","markdown":"https://secwatch.observer/filing/0001193125-26-329513.md","text":"https://secwatch.observer/filing/0001193125-26-329513.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625297/000119312526329513/0001193125-26-329513-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625297/000119312526329513/d28447d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-03T10:45:08.552150+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}